Omega Alpha SPAC (Omega Alpha SPAC) Inventory-to-Revenue : 0.00 (As of Sep. 2022)

---

Omega Alpha SPAC Inventory-to-Revenue Chart

---

Competitive Comparison of Omega Alpha SPAC's Inventory-to-Revenue

For the Shell Companies subindustry, Omega Alpha SPAC's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

---

Omega Alpha SPAC's Inventory-to-Revenue Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Omega Alpha SPAC's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Omega Alpha SPAC's Inventory-to-Revenue falls into.

---

Omega Alpha SPAC Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Omega Alpha SPAC's Inventory-to-Revenue for the fiscal year that ended in Dec. 2021 is calculated as

Omega Alpha SPAC's Inventory-to-Revenue for the quarter that ended in Sep. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

---

Omega Alpha SPAC  (NAS:OMEG) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Omega Alpha SPAC's Days Inventory for the three months ended in Sep. 2022 is calculated as:

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Omega Alpha SPAC's Inventory Turnover for the quarter that ended in Sep. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

---

Omega Alpha SPAC Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Omega Alpha SPAC's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Total Inventories Revenue Days Inventory Cost of Goods Sold Inventory Turnover

---

Omega Alpha SPAC (Omega Alpha SPAC) Business Description

Executives

Otello Stampacchia	director, 10 percent owner, officer: Chief Executive Officer	888 BOYLSTON ST., SUITE 1111, BOSTON MA 02199
Alpha Management Omega	10 percent owner	888 BOYLSTON STREET, SUITE 1111, BOSTON MA 02119
Joseph P Slattery	director	C/O TRANSENTERIX, INC., 635 DAVIS DRIVE, SUITE 300, MORRISVILLE NC 27560
Martin Babler	director	C/O INFINITY PHARMACEUTICALS, INC., 780 MEMORIAL DRIVE, CAMBRIDGE MA 02139
Daniel Lynch	director
Vincent Ossipow	officer: Chief Scientific Officer	CH. DES VIGNES 1, COMMUGNY V8 1291
Van De Winkel Jan	director	C/O HOOKIPA PHARMA INC., 430 EAST 29TH STREET 14TH FLOOR, NEW YORK NY 10016
Omega Fund Vi, L.p.	10 percent owner	888 BOYLSTON ST., SUITE 1111, BOSTON MA 02199
Omega Fund Vi Gp Manager, Ltd.	10 percent owner	888 BOYLSTON STREET, SUITE 1111, BOSTON MA 02199
Omega Fund Vi Gp, L.p.	10 percent owner	888 BOYLSTON STREET, SUITE 1111, BOSTON MA 02199
Michelle Doig	director, officer: President	C/O OMEGA ALPHA SPAC, 888 BOYLSTON STREET SUITE 1111, BOSTON MA 02199
Francesco Draetta	officer: Chief Financial Officer	C/O OMEGA ALPHA SPAC, 888 BOYLSTON STREET SUITE 1111, BOSTON MA 02199
Alexandra Pearsall	10 percent owner	C/O OMEGA ALPHA SPAC, 888 BOYLSTON STREET, SUITE 1111, BOSTON MA 02199